Healthcare Analysts, ahead of the upcoming AASLD Annual Meeting, discuss emerging treatment options for Chronic Hepatitis B (relevant companies: ABUS, HOOK, BRNS, VIR, GSK, ALGS, GILD) on an Analyst/Industry conference call to be held on October 22.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABUS:
- Arbutus Biopharma Highlights Imdusiran’s Potential in Hepatitis B
- Arbutus Biopharma announces abstracts highlighting imdusiran data
- Arbutus Biopharma CSO Michael Sofia Announces Retirement Plans
- Arbutus Biopharma to Share Insights at Viral Hepatitis Conference
- Biotech Alert: Searches spiking for these stocks today